% FDA Approves Olumiant for Hair Loss From Alopecia Areata Everyday Health MenuNewslettersSearch Hair Loss
News
FDA Approves New Treatment Olumiant for Hair Loss From Severe Alopecia Areata
Nearly 2 in 5 participants in clinical trials for the drug achieved significant hair regrowth. By Becky UphamJune 15, 2022Fact-CheckedOlumiant prevents the immune system from attacking hair follicles.Eli Lilly, CanvaOn June 13, the U.S.
thumb_upLike (0)
commentReply (2)
shareShare
visibility855 views
thumb_up0 likes
comment
2 replies
C
Christopher Lee 1 minutes ago
Food and Drug Administration (FDA) approved the drug baricitinib (Olumiant) for severe alopecia area...
L
Luna Park 3 minutes ago
People with severe alopecia areata may also lose eyebrows and eyelashes. “Access to safe and effec...
E
Emma Wilson Admin
access_time
2 minutes ago
Saturday, 03 May 2025
Food and Drug Administration (FDA) approved the drug baricitinib (Olumiant) for severe alopecia areata (AA), an autoimmune disease that results in sudden and sometimes extreme hair loss. The once-a-day oral medication is the first FDA-approved systemic therapy for alopecia areata, meaning it treats the entire body rather than a specific area. Alopecia areata affects more than 300,000 people in the United States each year, often leading to bald patches on the scalp.
thumb_upLike (35)
commentReply (2)
thumb_up35 likes
comment
2 replies
N
Nathan Chen 2 minutes ago
People with severe alopecia areata may also lose eyebrows and eyelashes. “Access to safe and effec...
L
Lily Watson 1 minutes ago
“Today’s approval will help fulfill a significant unmet need for patients with severe alopecia a...
E
Elijah Patel Member
access_time
9 minutes ago
Saturday, 03 May 2025
People with severe alopecia areata may also lose eyebrows and eyelashes. “Access to safe and effective treatment options is crucial for the significant number of Americans affected by severe alopecia,” said Kendall Marcus, MD, the director of the division of dermatology and dentistry in the FDA’s Center for Drug Evaluation and Research, in an FDA press release.
thumb_upLike (35)
commentReply (2)
thumb_up35 likes
comment
2 replies
B
Brandon Kumar 4 minutes ago
“Today’s approval will help fulfill a significant unmet need for patients with severe alopecia a...
E
Evelyn Zhang 8 minutes ago
“With this approval, we now have a once-a-day medication that can help patients have significant h...
N
Natalie Lopez Member
access_time
16 minutes ago
Saturday, 03 May 2025
“Today’s approval will help fulfill a significant unmet need for patients with severe alopecia areata.”
Frustrated by the limited number of treatment options, many individuals with AA turn to wigs, false eyelashes, or eyebrow tattoos, says Lotus Mallbris, MD, the vice president of immunology development for Eli Lilly, the company that produces baricitinib. “People with alopecia areata face significant challenges, as the disease can be very stigmatizing,” Dr. Mallbris says.
thumb_upLike (12)
commentReply (3)
thumb_up12 likes
comment
3 replies
J
Joseph Kim 4 minutes ago
“With this approval, we now have a once-a-day medication that can help patients have significant h...
B
Brandon Kumar 10 minutes ago
It gives many patients better access to a medication that can help them get their hair back and impr...
“With this approval, we now have a once-a-day medication that can help patients have significant hair growth and eyebrow and eyelash growth,” she says. Before the approval of baricitinib, there were zero FDA-approved therapies for the treatment of alopecia areata, says Kristen Lo Sicco, MD, associate professor of dermatology and the director of the skin and cancer unit at NYU Langone Medical Center in New York City. “This approval is huge, both for people with alopecia areata and the clinicians who have been advocating for them.
thumb_upLike (3)
commentReply (2)
thumb_up3 likes
comment
2 replies
C
Charlotte Lee 13 minutes ago
It gives many patients better access to a medication that can help them get their hair back and impr...
L
Lucas Martinez 8 minutes ago
A total of 1,200 people were included in the two trials: 51.7 percent of subjects were white, 36.3 p...
T
Thomas Anderson Member
access_time
6 minutes ago
Saturday, 03 May 2025
It gives many patients better access to a medication that can help them get their hair back and improve their quality of life,” says Dr. Lo Sicco.
Editor' s Picks
Will Popular Hair-Loss Products Help My Alopecia
Viral hair-loss products have been gaining popularity, but use caution before jumping on the bandwagon.…Learn More
Nearly 2 in 5 Study Participants Had Significant Hair Regrowth
Results from two phase 3 trials on baricitinib were published in The New England Journal of Medicine on May 5, 2022.
thumb_upLike (38)
commentReply (3)
thumb_up38 likes
comment
3 replies
L
Lucas Martinez 4 minutes ago
A total of 1,200 people were included in the two trials: 51.7 percent of subjects were white, 36.3 p...
M
Mia Anderson 3 minutes ago
In a pooled analysis of the two trials, patients had a mere 14.5 percent scalp hair coverage at the ...
A total of 1,200 people were included in the two trials: 51.7 percent of subjects were white, 36.3 percent were Asian, and 8.2 percent were Black. In both studies, participants were divided into three groups and received either 2 milligrams (mg) of baricitinib, 4 mg baricitinib, or placebo once a day, every day. To be included in the trial, people had to have severe alopecia, defined as at least 50 percent scalp hair loss for more than six months.
thumb_upLike (45)
commentReply (3)
thumb_up45 likes
comment
3 replies
D
Daniel Kumar 9 minutes ago
In a pooled analysis of the two trials, patients had a mere 14.5 percent scalp hair coverage at the ...
J
Jack Thompson 13 minutes ago
After a year, nearly 3 in 4 of those people achieved 90 percent scalp hair coverage. Lo Sico notes t...
In a pooled analysis of the two trials, patients had a mere 14.5 percent scalp hair coverage at the start of the study. The pooled analysis found that 39 percent of the people who took the 4 mg dose of baricitinib achieved significant scalp hair regrowth, defined as 80 percent or more scalp hair coverage. Reaching 80 percent scalp hair coverage is a dramatic improvement: At that point, the disease is no longer visible, says Mallbris.
thumb_upLike (8)
commentReply (3)
thumb_up8 likes
comment
3 replies
H
Henry Schmidt 21 minutes ago
After a year, nearly 3 in 4 of those people achieved 90 percent scalp hair coverage. Lo Sico notes t...
N
Noah Davis 1 minutes ago
“Many patients are pleased when they have above 50 to 60 percent of hair coverage,” she says. Se...
After a year, nearly 3 in 4 of those people achieved 90 percent scalp hair coverage. Lo Sico notes that 80 and 90 percent hair regrowth is a high bar that is set by the U.S. and European FDAs respectively.
thumb_upLike (13)
commentReply (3)
thumb_up13 likes
comment
3 replies
L
Luna Park 33 minutes ago
“Many patients are pleased when they have above 50 to 60 percent of hair coverage,” she says. Se...
D
Dylan Patel 27 minutes ago
Separately, about 1 in 5 had regrowth in eyebrow hair and 1 in 4 had regrowth in eyelash hair. In ma...
“Many patients are pleased when they have above 50 to 60 percent of hair coverage,” she says. Separately, more than 40 percent of study participants had full regrowth in eyebrow and eyelash hair or regrowth with minimal gaps. In the group that took 2 mg of baricitinib, 22.6 percent of participants reached the 80 percent threshold of hair growth.
thumb_upLike (47)
commentReply (1)
thumb_up47 likes
comment
1 replies
A
Audrey Mueller 11 minutes ago
Separately, about 1 in 5 had regrowth in eyebrow hair and 1 in 4 had regrowth in eyelash hair. In ma...
V
Victoria Lopez Member
access_time
33 minutes ago
Saturday, 03 May 2025
Separately, about 1 in 5 had regrowth in eyebrow hair and 1 in 4 had regrowth in eyelash hair. In many study participants who took the higher dose of baricitinib (Olumiant), hair loss was no longer visible.Massachusetts Medical Society
What Is Alopecia Areata
In people with alopecia areata, often referred to as simply “alopecia,” the immune system attacks hair follicles, causing inflammation and hair loss. As long as the immune system continues to attack the follicles, hair doesn’t grow back, according to the National Institutes of Health.
thumb_upLike (36)
commentReply (3)
thumb_up36 likes
comment
3 replies
V
Victoria Lopez 23 minutes ago
In alopecia areata, many people lose clumps of hair in small circular patches about the size of a qu...
L
Liam Wilson 25 minutes ago
Some people will go on to experience hair regrowth, while others will see additional bare patches de...
In alopecia areata, many people lose clumps of hair in small circular patches about the size of a quarter. Hair loss typically begins suddenly, and people with the disease are usually healthy and have no other symptoms.
thumb_upLike (38)
commentReply (0)
thumb_up38 likes
L
Liam Wilson Member
access_time
26 minutes ago
Saturday, 03 May 2025
Some people will go on to experience hair regrowth, while others will see additional bare patches develop, or small patches of hair loss join together and form larger areas of baldness. The condition, once relatively unknown, has been in the spotlight in the last few months.
thumb_upLike (16)
commentReply (3)
thumb_up16 likes
comment
3 replies
B
Brandon Kumar 24 minutes ago
The actor and talk-show host Jada Pinkett Smith revealed she has alopecia and had made the choice to...
A
Amelia Singh 25 minutes ago
There are several forms of alopecia areata. Alopecia totalis involves total loss of hair on the head...
The actor and talk-show host Jada Pinkett Smith revealed she has alopecia and had made the choice to shave her head. Her husband, the actor Will Smith, slapped the comedian Chris Rock at the Academy Awards after Rock made a comment about Ms. Smith’s appearance.
thumb_upLike (4)
commentReply (2)
thumb_up4 likes
comment
2 replies
J
James Smith 49 minutes ago
There are several forms of alopecia areata. Alopecia totalis involves total loss of hair on the head...
E
Elijah Patel 20 minutes ago
Approval Helps Substantiate Alopecia Areata as a True Medical Condition
Historically, insur...
D
David Cohen Member
access_time
30 minutes ago
Saturday, 03 May 2025
There are several forms of alopecia areata. Alopecia totalis involves total loss of hair on the head, while alopecia universalis causes complete loss of hair on the head, face, and body.
thumb_upLike (33)
commentReply (2)
thumb_up33 likes
comment
2 replies
H
Henry Schmidt 25 minutes ago
Approval Helps Substantiate Alopecia Areata as a True Medical Condition
Historically, insur...
C
Chloe Santos 6 minutes ago
Lo Sicco emphasizes that a patient’s decision about whether or not to pursue treatment for AA is a...
N
Noah Davis Member
access_time
32 minutes ago
Saturday, 03 May 2025
Approval Helps Substantiate Alopecia Areata as a True Medical Condition
Historically, insurance companies have viewed hair loss as a cosmetic rather than a medical issue and used this rationale to deny coverage for treatment, says Lo Sicco. “That’s why this approval is so significant for this patient population — it helps substantiate alopecia areata as a true medical condition,” she says.
thumb_upLike (48)
commentReply (1)
thumb_up48 likes
comment
1 replies
A
Aria Nguyen 7 minutes ago
Lo Sicco emphasizes that a patient’s decision about whether or not to pursue treatment for AA is a...
T
Thomas Anderson Member
access_time
17 minutes ago
Saturday, 03 May 2025
Lo Sicco emphasizes that a patient’s decision about whether or not to pursue treatment for AA is a personal choice. “Most of the people who come to the clinic for their alopecia areata are interested in pursuing treatment to get their hair back, but I never press treatment on somebody,” she says.
thumb_upLike (0)
commentReply (1)
thumb_up0 likes
comment
1 replies
C
Charlotte Lee 9 minutes ago
“It is my role as a clinician to provide information regarding therapeutic choices for my patients...
K
Kevin Wang Member
access_time
18 minutes ago
Saturday, 03 May 2025
“It is my role as a clinician to provide information regarding therapeutic choices for my patients to make an informed decision regarding their AA treatment options.”
Baricitinib Works by Reducing Inflammation
Baricitinib is part of a class of drugs known as Janus kinase (JAK) inhibitors. JAKs are enzymes that transmit signals for cell processes, including immune response, stimulating immune cells to produce inflammatory proteins. JAK inhibitors interrupt the transmission of the signals and reduce inflammation.
thumb_upLike (36)
commentReply (2)
thumb_up36 likes
comment
2 replies
L
Liam Wilson 1 minutes ago
Researchers have been studying a number of JAK inhibitors as treatments for severe alopecia areata, ...
H
Henry Schmidt 17 minutes ago
Steroid injections to areas of hair loss can suppress the immune system so hair can regrow. Another ...
G
Grace Liu Member
access_time
38 minutes ago
Saturday, 03 May 2025
Researchers have been studying a number of JAK inhibitors as treatments for severe alopecia areata, including tofacitinib and ruxolitinib, according to the American Academy of Dermatology Association, which calls this a “major research breakthrough.” Baricitinib is the first JAK inhibitor to receive FDA approval for severe alopecia areata. People with alopecia areata have limited treatment options.
thumb_upLike (44)
commentReply (3)
thumb_up44 likes
comment
3 replies
B
Brandon Kumar 36 minutes ago
Steroid injections to areas of hair loss can suppress the immune system so hair can regrow. Another ...
C
Chloe Santos 31 minutes ago
The FDA Has Also Approved Baricitinib to Treat People With RA and Hospitalized COVID-19 Patients...
Steroid injections to areas of hair loss can suppress the immune system so hair can regrow. Another therapy is the topical application of an irritant such as squaric acid, which creates a rash similar to poison ivy that distorts the immune system’s attack on the hair follicles, according to Yale Medicine.
thumb_upLike (42)
commentReply (0)
thumb_up42 likes
A
Alexander Wang Member
access_time
42 minutes ago
Saturday, 03 May 2025
The FDA Has Also Approved Baricitinib to Treat People With RA and Hospitalized COVID-19 Patients
Baricitinib was approved by the FDA in 2018 to treat rheumatoid arthritis (RA), and it’s also been used to treat people who are hospitalized with COVID-19. Baricitinib was granted an emergency use authorization (EUA) in November 2020 to be used in combination with remdesivir for treating people 2 years old and older who are hospitalized with COVID-19 and who require supplemental oxygen or who are on a ventilator.
thumb_upLike (47)
commentReply (2)
thumb_up47 likes
comment
2 replies
E
Evelyn Zhang 37 minutes ago
In July 2021 the drug was granted an EUA to be used as a standalone treatment, and in May 2022, it w...
Z
Zoe Mueller 28 minutes ago
The most common side effects associated with baricitinib are upper respiratory tract infections, hea...
D
David Cohen Member
access_time
110 minutes ago
Saturday, 03 May 2025
In July 2021 the drug was granted an EUA to be used as a standalone treatment, and in May 2022, it was granted full approval, making it the first immunomodulatory treatment to receive FDA approval.
Common Side Effects and Warnings for People Taking Baricitinib
In both New England Journal of Medicine studies, baricitinib’s safety in treating alopecia areata was on par with that in patients who take the drug for rheumatoid arthritis.
thumb_upLike (37)
commentReply (2)
thumb_up37 likes
comment
2 replies
A
Ava White 103 minutes ago
The most common side effects associated with baricitinib are upper respiratory tract infections, hea...
I
Isaac Schmidt 43 minutes ago
Each patient should talk to their doctor about their personal and family health history and specific...
R
Ryan Garcia Member
access_time
115 minutes ago
Saturday, 03 May 2025
The most common side effects associated with baricitinib are upper respiratory tract infections, headache, acne, high cholesterol, increases in muscle-related blood markers (which can indicate muscle damage), urinary tract infection, liver enzyme elevations, inflammation of hair follicles (folliculitis), fatigue, lower respiratory tract infections, nausea, genital yeast infections (candida infections), anemia, low number of certain types of white blood cells (neutropenia), abdominal pain, shingles (herpes zoster), and weight increase. While the FDA has judged baricitinib to be safe and effective, the agency requires the medication to carry a black box warning for rare but potentially serious complications such as infections, mortality, malignancy, major adverse cardiovascular events, and thrombosis. A black box warning is the FDA’s most stringent warning for drugs and medical devices on the market.
thumb_upLike (27)
commentReply (1)
thumb_up27 likes
comment
1 replies
M
Mason Rodriguez 112 minutes ago
Each patient should talk to their doctor about their personal and family health history and specific...
C
Charlotte Lee Member
access_time
48 minutes ago
Saturday, 03 May 2025
Each patient should talk to their doctor about their personal and family health history and specific risk factors when considering starting baricitinib for AA, says Lo Sicco.
How Much Will Baricitinib Cost
The list price of Olumiant is $2,497.20 for a 30-day supply of 2 mg tablets, but the actual cost of the drug for treating alopecia areata will vary according to the dose (2 mg or 4 mg) and insurance coverage.
thumb_upLike (31)
commentReply (2)
thumb_up31 likes
comment
2 replies
N
Natalie Lopez 40 minutes ago
NEWSLETTERS
Sign up for our Healthy Living Newsletter
SubscribeBy subscribing you agree to...
M
Mason Rodriguez 13 minutes ago
Here’s how to approach the dating scene with greater confidence and stay true to yourself...By Eri...
Z
Zoe Mueller Member
access_time
50 minutes ago
Saturday, 03 May 2025
NEWSLETTERS
Sign up for our Healthy Living Newsletter
SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy.
The Latest in Hair Loss
11 Potential Causes of Hair Loss and Baldness
By Kristeen Cherney, PhDOctober 7, 2022
Oral Minoxidil for Hair Loss 9 Things You Need to Know
Some dermatologists are prescribing this blood pressure medication off-label to treat hair loss — but is it safe?By Lisa RapaportSeptember 21, 2022
Will Popular Hair-Loss Products Help My Alopecia
Viral hair-loss products have been gaining popularity, but use caution before jumping onthe bandwagon.By Emilia BentonAugust 25, 2022
4 Real-Life Dating Tips for People Living With Alopecia
Dating is tough for anyone, especially if you have hair loss.
thumb_upLike (7)
commentReply (3)
thumb_up7 likes
comment
3 replies
A
Ava White 8 minutes ago
Here’s how to approach the dating scene with greater confidence and stay true to yourself...By Eri...
J
Joseph Kim 23 minutes ago
FDA Approves Olumiant for Hair Loss From Alopecia Areata Everyday Health MenuNewslettersSearch ...
Here’s how to approach the dating scene with greater confidence and stay true to yourself...By Erica PatinoAugust 17, 2022
Life With Alopecia Your Guide to Microblading Eyelash Extensions and More
You don’t have to settle for patchy eyebrows and sparse lashes. These cosmetic treatments can help when hair loss affects your face.By Jennifer Kelly GeddesAugust 16, 2022
Causes and Risk Factors for Alopecia Areata
By Kristeen Cherney, PhDJune 16, 2022
What Are the Treatment Options for Alopecia Universalis
By Kristeen Cherney, PhDJune 15, 2022
How to Cope With Hair Loss From Alopecia Areata
By Kristeen Cherney, PhDJune 15, 2022
What Are the Different Types of Alopecia Areata
By Kristeen Cherney, PhDJune 15, 2022
What Are the Treatment Options for Alopecia Areata
By Kristeen Cherney, PhDJune 14, 2022See All MORE IN
Life With Alopecia Your Guide to Microblading Eyelash Extensions and More
Healthy Hair A Guide to Getting Full Shiny Strong Locks